Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | HMGCR | P04035 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | SLC13A5 | Q86YT5 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ACLY | P53396 | 3/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.38 |
| ▸ | CPT2 | P23786 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL346699 | 1.00 | ALDH1A1 (0.70) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL23607610 | 0.97 | ALDH1A1 (0.67) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL31078055 | 0.97 | ALDH1A1 (0.67) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL31272367 | 0.86 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL437150 | 0.84 | ALDH1A1 (0.79) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL31223219 | 0.84 | ALDH1A1 (0.79) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL31223216 | 0.84 | ALDH1A1 (0.79) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL6429247 | 0.84 | ALDH1A1 (0.79) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL226489 | 0.84 | ALDH1A1 (0.79) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL28846450 | 0.84 | ALDH1A1 (0.79) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024140874-A1 | IRON COMPLEX, PREPARATION METHOD THEREFOR, COMPOSITION, SLURRY, AND APPLICATION | 华为技术有限公司 | 2024-07-04 | — | — | WO | claimed |
| CN-117779011-A | Wafer electroless tungsten plating alloy solution, preparation method and electroless tungsten plating method | 昆山一鼎工业科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| EP-4087624-A1 | FLEXIBLE GELATIN SEALANT DRESSING WITH REACTIVE COMPONENTS | Ethicon, Inc (US) | 2022-11-16 | — | — | EP | claimed |
| CN-114929294-A | Flexible gelatin sealant dressing with reactive components | 爱惜康股份有限公司 | 2022-08-19 | — | — | CN | claimed |
| US-20220112506-A1 | MOLECULAR SWITCHES | PRECIGEN, INC. (US) | 2022-04-14 | — | — | US | claimed |
| US-20170152529-A1 | Biological Production of Multi-Carbon Compounds from Methane | INTREXON CORPORATION (US) | 2017-06-01 | — | — | US | claimed |
| US-20140273128-A1 | Biological Conversion of Multi-Carbon Compounds from Methane | INTREXON CORPORATION (US) | 2014-09-18 | — | — | US | claimed |
| US-12622982-B2 | Implants and biodegradable tissue markers | INCEPT, LLC (US) | 2026-05-12 | — | — | US | disclosed |
| US-12595494-B2 | Biological production of multi-carbon compounds from methane | BIOVERDE TECH LLC (US) | 2026-04-07 | — | — | US | disclosed |
| EP-4032563-B1 | CHITOSAN AND POLYETHYLENE GLYCOL COPOLYMERS AND METHODS AND DEVICES FOR USING SAME FOR SEALING A VASCULAR PUNCTURE | ACCESS CLOSURE INC (US) | 2026-01-07 | — | — | EP | disclosed |
| EP-3519579-B1 | PROCESSES TO PREPARE ELONGATED 2-KETOACIDS AND C-5-C10 COMPOUNDS THEREFROM VIA GENETIC MODIFICATIONS TO MICROBIAL METABOLIC PATHWAYS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-11-05 | — | — | EP | disclosed |
| US-12350397-B2 | Superabsorbent, freeze dried hydrogels for medical applications | INCEPT LLC (US) | 2025-07-08 | — | — | US | disclosed |
| US-20250161497-A1 | IMPLANTS AND BIODEGRADABLE TISSUE MARKERS | INCEPT, LLC | 2025-05-22 | — | — | US | disclosed |
| US-20090099364-A1 | Process for preparation of 1-(2s,3s)-2-benzhydryl-n-(5- tert-butyl-2-methoxybenzyl)quinuclidin-3-amine | PFIZER INC. | 2009-04-16 | — | — | US | disclosed |
| US-20090081746-A1 | BIOFUEL PRODUCTION BY RECOMBINANT MICROORGANISMS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-03-26 | — | — | US | disclosed |
| US-20090017097-A1 | Hydrogel polymeric compositions and methods | OCULAR THERAPEUTIX, INC. | 2009-01-15 | — | — | US | disclosed |
| WO-2009008946-A1 | HYDROGEL POLYMERIC COMPOSITIONS AND METHODS | INCEPT, LLC. (US) | 2009-01-15 | — | — | WO | disclosed |
| US-7318477-B2 | Method and composition for cleaning a well bore prior to cementing | AKZO NOBEL N.V. (NL) | 2008-01-15 | — | — | US | disclosed |
| US-20050118665-A1 | Methods for conducting assays for enzyme activity on protein microarrays | PROTOMETRIX, INC. | 2005-06-02 | — | — | US | disclosed |
| US-4992544-A | Intermediates for b-lactam antibiotics and b-lactamase inhibitor | UNIVERSITY OF NOTRE DAME DU LAC (US) | 1991-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595494-B2 | Biological production of multi-carbon compounds from methane | MLYCD, ADH1C, DERA | ALDH1A1 257/4885HMGCR 526/4885CHRM1 3123/4885 |
| US-20090099364-A1 | Process for preparation of 1-(2s,3s)-2-benzhydryl-n-(5- tert-butyl-2-methoxybenzyl)quinuclidin-3-amine | CS, GATD3, AQP1 | ALDH1A1 690/4885HMGCR 1712/4885CHRM1 343/4885 |
| US-12622982-B2 | Implants and biodegradable tissue markers | CD44, MUC1, FUCA1 | ALDH1A1 1056/4885HMGCR 2949/4885CHRM1 3230/4885 |
| US-20090017097-A1 | Hydrogel polymeric compositions and methods | CRYAA, CRYAB, UACA | ALDH1A1 1593/4885HMGCR 1765/4885CHRM1 4205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.